These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 19291500

  • 1. Memantine (Namenda, Forest Pharmaceuticals).
    Roman MW.
    Issues Ment Health Nurs; 2009 Mar; 30(3):202. PubMed ID: 19291500
    [No Abstract] [Full Text] [Related]

  • 2. Memantine (Namenda) for moderate to severe Alzheimer's disease.
    Ables AZ.
    Am Fam Physician; 2004 Mar 15; 69(6):1491-2. PubMed ID: 15053415
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Memantine: the next trend in academic performance enhancement?
    Ota KS, Godwin T.
    J Am Osteopath Assoc; 2006 Jun 15; 106(6):358-9. PubMed ID: 16790543
    [No Abstract] [Full Text] [Related]

  • 8. Exacerbation of myoclonus by memantine in a patient with Alzheimer disease.
    Papageorgiou SG, Kontaxis T, Antelli A, Kalfakis N.
    J Clin Psychopharmacol; 2007 Aug 15; 27(4):407-8. PubMed ID: 17632233
    [No Abstract] [Full Text] [Related]

  • 9. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
    Rabins PV, Lyketsos CG.
    Nat Clin Pract Neurol; 2006 Nov 15; 2(11):578-9. PubMed ID: 17057739
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Drug for moderate to advanced Alzheimer's approved.
    Mayo Clin Health Lett; 2004 Feb 15; 22(2):4. PubMed ID: 15032170
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Memantine in moderate-to-severe Alzheimer's disease.
    Bleich S, Wiltfang J, Kornhuber J.
    N Engl J Med; 2003 Aug 07; 349(6):609-10; author reply 609-10. PubMed ID: 12904528
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Antibodies, antihypertensive drugs, antioxidants. Can they prevent Alzheimer disease?].
    MMW Fortschr Med; 2003 Aug 21; 145(33-34):60. PubMed ID: 14526584
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stroke, Alzheimer's patients may benefit from AIDS dementia drug.
    Dent Today; 1997 Feb 21; 16(2):29. PubMed ID: 9560599
    [No Abstract] [Full Text] [Related]

  • 19. FDA approves groundbreaking Alzheimer's drug.
    Provider; 2004 Feb 21; 30(2):24, 27. PubMed ID: 14964917
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI).
    Ferris S, Schneider L, Farmer M, Kay G, Crook T.
    Int J Geriatr Psychiatry; 2007 May 21; 22(5):448-55. PubMed ID: 17117395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.